Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional

Safety and Efficacy of Luliconazole Solution, 10% in Subjects With Mild to Moderate Onychomycosis

ClinicalTrials.gov ID: NCT01431820

Public ClinicalTrials.gov record NCT01431820. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 10:41 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety and Efficacy of Luliconazole Solution, 10% With Two Dosing Regimens in Distal Subungual Onychomycosis of the Toenails: A Randomized, Double-Blind, Vehicle-Controlled, Phase 2B/3 Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the safety and efficacy of a topical antifungal formulation, Luliconazole Solution, 10%, in the treatment of adults with onychomycosis of the toenails.

Study identification

NCT ID
NCT01431820
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Topica Pharmaceuticals
Industry
Enrollment
334 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2012 (Type not available)
Primary completion
Jun 2014 (Actual)
Completion
Aug 2014 (Actual)
Last update posted
Nov 30, 2015

2012 – 2014

United States locations

U.S. sites
28
U.S. states
19
U.S. cities
26
Facility City State ZIP Site status
Not listed Phoenix Arizona 85050 —
Not listed Los Angeles California 90045 —
Not listed San Diego California 92119 —
Not listed San Diego California 92123 —
Not listed Denver Colorado 80210 —
Not listed Aventura Florida 33180 —
Not listed Miami Florida 33175 —
Not listed Boise Idaho 83704 —
Not listed Evansville Indiana 47714 —
Not listed Louisville Kentucky 40202 —
Not listed Baltimore Maryland 21214 —
Not listed Detroit Michigan 48202 —
Not listed Fridley Minnesota 55432 —
Not listed Albuquerque New Mexico 87106 —
Not listed East Setauket New York 11733 —
Not listed Rochester New York 14623 —
Not listed Cincinnati Ohio 45249 —
Not listed Portland Oregon 97210 —
Not listed Portland Oregon 97223 —
Not listed Knoxville Tennessee 37922 —
Not listed Nashville Tennessee 37215 —
Not listed Austin Texas 78759 —
Not listed College Station Texas 77840 —
Not listed Dallas Texas 75243 —
Not listed San Antonio Texas 78229 —
Not listed Salt Lake City Utah 84117 —
Not listed Lynchburg Virginia 24501 —
Not listed Madison Wisconsin 53719 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01431820, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 30, 2015 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01431820 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →